CAPTRUST Financial Advisors
AMED

CAPTRUST Financial Advisors’s Amedisys AMED Stock Holding History

CAPTRUST Financial Advisors’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-2,819
Closed -$268K – 2156
2023
Q4 		$268K Buy
2,819
+162
+6% +$15.1K ﹤0.01% 2188
2023
Q3 		$248K Sell
2,657
-6,282
-70% -$580K ﹤0.01% 2142
2023
Q2 		$817K Sell
8,939
-247
-3% -$20.3K ﹤0.01% 1329
2023
Q1 		$676K Buy
9,186
+651
+8% +$56.3K ﹤0.01% 1248
2022
Q4 		$713K Buy
8,535
+2,621
+44% +$236K ﹤0.01% 1152
2022
Q3 		$572K Sell
5,914
-521
-8% -$62.1K ﹤0.01% 1189
2022
Q2 		$676K Buy
6,435
+1,070
+20% +$137K ﹤0.01% 1018
2022
Q1 		$924K Buy
5,365
+1,795
+50% +$268K 0.01% 880
2021
Q4 		$578K Sell
3,570
-558
-14% -$89.7K ﹤0.01% 1047
2021
Q3 		$615K Sell
4,128
-2,390
-37% -$497K 0.01% 943
2021
Q2 		$1.6M Sell
6,518
-1,508
-19% -$396K 0.01% 563
2021
Q1 		$2.13M Buy
8,026
+624
+8% +$176K 0.02% 452
2020
Q4 		$2.17M Sell
7,402
-329
-4% -$84.4K 0.03% 390
2020
Q3 		$1.82M Sell
7,731
-29
-0.4% -$6.59K 0.03% 360
2020
Q2 		$1.6M Sell
7,760
-4
-0.1% -$746 0.03% 396
2020
Q1 		$1.34M Buy
7,764
+30
+0.4% +$5.34K 0.03% 369
2019
Q4 		$1.28M Buy
7,734
+6,909
+837% +$1.03M 0.02% 456
2019
Q3 		$108K Buy
825
+75
+10% +$9.76K ﹤0.01% 752
2019
Q2 		$91K Buy
750
+153
+26% +$18.2K ﹤0.01% 787
2019
Q1 		$74K Hold
597
– – ﹤0.01% 797
2018
Q4 		$70K Buy
597
+369
+162% +$43.5K ﹤0.01% 679
2018
Q3 		$28K Sell
228
-106
-32% -$11.7K ﹤0.01% 903
2018
Q2 		$29K Sell
334
-15
-4% -$1.1K ﹤0.01% 838
2018
Q1 		$21K Buy
349
+122
+54% +$6.95K ﹤0.01% 811
2017
Q4 		$12K Buy
+227
New +$12K ﹤0.01% 939

Other funds holding AMED

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return

CAPTRUST Financial Advisors's AMED Position: Q1 2024 in Review

CAPTRUST Financial Advisors sold out of Amedisys (AMED) in Q1 2024, closing a stake of 2,819 shares — an estimated $268K sold.

CAPTRUST Financial Advisors first reported a position in AMED in Q4 2017 and held it in 25 quarters. The position peaked at $2.17M in Q4 2020. 283 funds tracked by Wall St. Rank hold AMED as of Q1 2024.

  • CAPTRUST Financial Advisors reported no remaining Amedisys position as of Q1 2024 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 2,819 Amedisys shares in Q1 2024, an estimated $268K.
  • CAPTRUST Financial Advisors first reported a position in Amedisys in Q4 2017 and held it in 25 quarters.
  • CAPTRUST Financial Advisors's Amedisys position peaked at $2.17M in Q4 2020.
  • 283 funds tracked by Wall St. Rank held Amedisys as of Q1 2024.

Based on CAPTRUST Financial Advisors's 13F filing for Q1 2024, filed 15 May 2024.